全球互聯藥物輸送設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，連網藥物輸送設備的市場規模將從 2025 年的 100.3 億美元達到 696.1 億美元，並預計從 2026 年到 2034 年將以 24.02% 的複合年成長率成長。

隨著數位醫療技術的廣泛應用，全球互聯藥物輸送設備市場正迅速成長。這些設備整合了互聯功能，能夠即時監測劑量、用藥依從性和患者健康數據。糖尿病和氣喘等慢性疾病的日益普遍是推動智慧吸入器和胰島素筆需求成長的主要因素。

關鍵成長要素包括遠端醫療服務的擴展、對遠端患者監護需求的成長以及物聯網醫療設備的進步。互聯藥物輸送系統可提高治療依從性，並為醫療服務提供者提供寶貴的數據。醫療保健領域數位化進程的加速和監管支持正進一步推動市場擴張。

展望未來，穿戴式裝置和行動整合裝置的持續技術創新預計將推動市場擴張。投資於數位醫療基礎設施的新興市場擁有強勁的成長潛力。透過與人工智慧 (AI) 和雲端分析技術的整合，設備功能有望得到提升。隨著以患者為中心的護理模式不斷發展，互聯藥物傳輸設備預計將廣泛應用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球互聯藥物輸送設備市場：依產品類型分類

• 市場分析、洞察與預測
• 獨立組件和軟體
• 整合設備

第5章 全球互聯藥物輸送設備市場：依給藥途徑分類

• 市場分析、洞察與預測
• 腸外
• 吸入

第6章 全球互聯藥物輸送設備市場：依應用分類

• 市場分析、洞察與預測
• 氣喘
• COPD
• 糖尿病管理
• 其他

第7章 全球互聯藥物輸送設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和分銷通路合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Teva Respiratory, LLC
  • Novo Nordisk A/S
  • Phillips-Medisize, LLC
  • Medtronic
  • Adherium Limited
  • Tandem Diabetes CareInc
  • Biocorp
  • Propeller Health
  • Ypsomed AG
  • Aptar Pharma

The Connected Drug Delivery Devices Market size is expected to reach USD 69.61 Billion in 2034 from USD 10.03 Billion (2025) growing at a CAGR of 24.02% during 2026-2034.

The Global Connected Drug Delivery Devices Market has grown rapidly due to increasing adoption of digital healthcare technologies. These devices integrate connectivity features to monitor dosage, adherence, and patient health data in real time. Rising prevalence of chronic diseases such as diabetes and asthma has significantly driven demand for smart inhalers and insulin pens.

Key growth drivers include the expansion of telehealth services, increasing demand for remote patient monitoring, and advancements in IoT-enabled medical devices. Connected drug delivery systems improve treatment adherence and provide valuable data for healthcare providers. Growing healthcare digitization initiatives and favorable regulatory support further boost market expansion.

Looking ahead, the market is expected to expand with continuous innovation in wearable and mobile-integrated devices. Emerging markets investing in digital health infrastructure will offer strong growth potential. Integration with artificial intelligence and cloud-based analytics will enhance device functionality. As patient-centered care models evolve, connected drug delivery devices are projected to gain widespread adoption.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Standalone Components & Software
• Integrated Devices

By Route of Administration

• Parenteral
• Inhalational

By Application

• Asthma
• COPD
• Diabetes Management
• Others

COMPANIES PROFILED

• Teva Respiratory, LLC, Novo Nordisk AS, PhillipsMedisize, LLC, Medtronic, Adherium Limited, Tandem Diabetes Care, Inc, Biocorp, Propeller Health, Ypsomed AG, Aptar Pharma

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Standalone Components & Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Integrated Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Inhalational Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. COPD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diabetes Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Route Of Administration
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Route Of Administration
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Route Of Administration
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Route Of Administration
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Route Of Administration
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CONNECTED DRUG DELIVERY DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Teva Respiratory, LLC
  • 9.2.2 Novo Nordisk A/S
  • 9.2.3 Phillips-Medisize, LLC
  • 9.2.4 Medtronic
  • 9.2.5 Adherium Limited
  • 9.2.6 Tandem Diabetes CareInc
  • 9.2.7 Biocorp
  • 9.2.8 Propeller Health
  • 9.2.9 Ypsomed AG
  • 9.2.10 Aptar Pharma